12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Other News

Siga, U.S. Department of Health and Human Services infectious news

Siga said it received a $79 million milestone payment from HHS's Biomedical Advanced Research and Development Authority (BARDA) following the third delivery of smallpox antiviral drug Arestvyr ( ST-246) to the U.S. government's strategic national stockpile. Siga said it has delivered a...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >